Clinical Trials Logo

Pediatric Tumor clinical trials

View clinical trials related to Pediatric Tumor.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04856020 Not yet recruiting - Pediatric Tumor Clinical Trials

Role of Gray Scale and Color Doppler Ultrasound in Diagnosis of Pediatric Neck Masses

Start date: April 2021
Phase:
Study type: Observational

Our aim is to assess the role of the gray scale and color Doppler ultrasound in diagnosis of the different pediatric neck masses .

NCT ID: NCT03728543 Not yet recruiting - Anesthesia Clinical Trials

the Efficacy and Safety of Sugammadex in Children 0-2 Years Old

Start date: November 15, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

Sugammadex is a selective antidote to muscle relaxants rocuronium bromide and vecuronium bromide. Sugammadex is a modified gamma-cyclodextrin, a compound that selectively binds rocuronium bromide and vecuronium bromide. It forms a complex with them in the blood plasma, which leads to the decrease in the concentration of muscle relaxant binding to nicotinic receptors in the neuromuscular synapse. The result is the the elimination of neuromuscular blockade caused by rocuronium bromide or vecuronium bromide. Sugammadex is used to eliminate neuromuscular blockade caused by rocuronium bromide in children aged 2 years and adolescents in standard clinical situations. The aim of the study is to prove the efficacy and safety of sugammadex in children under 2 years